Connection
Steven Rosenberg to Tumor Burden
This is a "connection" page, showing publications Steven Rosenberg has written about Tumor Burden.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.027 |
|
|
|
-
Chandran SS, Paria BC, Srivastava AK, Rothermel LD, Stephens DJ, Dudley ME, Somerville R, Wunderlich JR, Sherry RM, Yang JC, Rosenberg SA, Kammula US. Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans. Clin Cancer Res. 2015 Feb 01; 21(3):534-43.
Score: 0.027